Objective Performance of noninvasive prenatal screening (NIPS) methodologies when applied to low fetal fraction samples is not well established. The single-nucleotide polymorphism (SNP) method fails samples below a predetermined fetal fraction threshold, whereas some laboratories employing the whole-genome sequencing (WGS) method report aneuploidy calls for all samples. Here, the performance of the two methods was compared to determine which approach actually detects more fetal aneuploidies.
INTRODUCTION
Noninvasive prenatal screening (NIPS) for fetal aneuploidies using cell-free DNA (cfDNA) has been widely adopted in clinical practice due to its improved accuracy as compared to traditional screening approaches. 3 Consequently, both the American Congress of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics and Genomics (ACMG) recommend NIPS as a routine screening option. 4, 5 Such performance improvements have been enabled by developments in next-generation sequencing (NGS) technologies, which are employed by most clinical NIPS laboratories. NGS involves the generation of millions of short sequences ("reads"), each originating from a specific chromosomal segment, that provide information about both the genotype and relative abundance of the site in the genome (e.g., the X chromosome receives more reads in XX females than in XY males). 6 The two most widely offered NIPS methodologies differ based on which data they use to detect fetal aneuploidies. The single-nucleotide polymorphism approach ("SNP method"), measures the relative proportion of maternal and fetal genotypes among cfDNA fragments, and tests whether the observed patterns on specific chromosomes are more consistent with disomic or aneuploid fetal expectations. 7 Alternatively, the whole-genome sequencing approach ("WGS method"), measures the relative abundance of cfDNA from whole chromosomes in the maternal blood, testing whether certain chromosomes show elevated or reduced numbers of reads, consistent with fetal aneuploidies. 8 Despite differences
in the underlying signals, meta-analyses have found that both approaches share comparable clinical sensitivities for detecting common aneuploidies: trisomy 21 (Down syndrome, T21), trisomy 18 (Edwards syndrome, T18), trisomy 13 (Patau syndrome, T13), and monosomy X. 9, 10 A key concern has been how these methods perform on the minority of patients with low abundance of circulating fetal DNA (i.e., low fetal fraction samples), where separating signal from noise becomes challenging. 11 Low fetal fraction is associated with high maternal body-mass index and certain fetal aneuploidies. 3, 12, 13 In order to maintain high per-patient sensitivity, some tests avoid reporting results to patients with fetal fractions below a preset threshold, referred to as a "no-call" result. Patients who receive a "no-call" may submit a second blood draw or be offered invasive testing as higher rates of aneuploidy have been reported in such samples. 14 However, it is not clear that the strategy of combining "no-calling" with invasive diagnostic follow-up improves the detection rate of fetal aneuploidies as compared to simply calling low fetal fraction samples with reduced sensitivity: clinical experience shows that only 56.5% of patients submit a second sample and at least 25% of these fail again due to low fetal fraction. [12] [13] [14] Consequently, both ACOG and ACMG recommend that patients receiving a "no-call" be offered invasive diagnostic testing and that a second blood draw is not appropriate (2, 3 ). Yet compliance with this recommendation is far from perfect: even among women who screen positive for aneuploidies using either NIPS or conventional screening methods, only~55% seek confirmatory invasive testing. 12, 15 Finally, an additional consideration is that invasive tests cause procedure-related pregnancy loss in approximately one in 500 cases, which could affect a substantial number of patients in the context of routine NIPS. 16 In this study we use up-to-date published validation reports to model the performance of the WGS and SNP methods at low fetal fractions in order to determine whether returning a "no-call" result leads to a higher rate of detection of common aneuploidies as opposed to providing results for all cases regardless of fetal fraction.
METHODS

Simulating the WGS method
A detailed description of the equations and procedures underlying both methods is available in the Supplementary Material accompanying this manuscript and all code used to generate and analyze the data is available at https://github. com/counsylresearch/artieri_et_al_nips_at_low_ff. Here we briefly outline the key references and assumptions used to assess their performance. The WGS method was simulated according to the parameters in Jensen et al. 17 : 16 million reads per sample counted in 50 kb bins along chromosomes 21, 18, and 13 (we show in Supplemental Figure S1 that results remain unchanged when both methods are simulated at the same sequencing depth). Chromosomal sizes, (GRCh37/hg19, Feb. 2009) 18 were reduced by 10% to account for exclusion of poorly performing bins (resulting from high-GC content or the presence of repetitive elements). 17 As proper normalization leads to bin counts being distributed according to Poisson expectations (Supplemental Figure S2) , 19 bin depths were sampled from a Poisson distribution with mean based on chromosomal ploidy and fetal fraction (see Supplemental Methods). Sample-specific z-scores for each chromosome were generated by simulating batches of 100 samples (as could be run on a single Illumina v4 High Output sequencing flowcell on a HiSeq 2500 instrument [Illumina, San Diego, CA, USA]), randomly drawn from a population with trisomy prevalence of 3.3%, T21; 1.5%, T18, 0.5%, T13. 10 A single z-score from each of a disomic and trisomic sample (if present) were chosen at random from each batch until 10,000 of each were sampled at a given fetal fraction. The number of permutations was chosen such that repeated iterations of the same analysis would not produce significant differences in conclusions due to stochastic variation during in silico sampling. Samples were called trisomic if their z-score was greater or equal to three. Sensitivity was calculated as the fraction of trisomic samples correctly called, while specificity was the fraction of disomic samples not called trisomic.
Simulating the SNP method
For the SNP method, parameters were obtained from Ryan et al. 14 Figures S3-6 ). Samples were simulated in accordance with allele distributions as expected based on the parent-and meiotic-stage-of-origin of the trisomy and classified according to the approach outlined in Rabinowitz et al. 21 (see Supplemental Material).
Sensitivity of the SNP method at each fetal fraction was calculated by simulating 10,000 samples for each of the four types of meiotic nondisjunction and determining the proportion of trisomic samples for which the trisomy hypothesis had log-odds ratio (LOR) below the threshold at which 99.87% of disomic samples would be called disomic (corresponding to the same specificity as the WGS test). The aggregate sensitivity of the SNP method was determined by calculating the weighted expectation of the sensitivity of detection of each fetal ploidy hypothesis multiplied by its prevalence. 22 
Determining clinical outcomes
The proportion of patients who submit redraws, 56.5%, was obtained from Dar et al. 12 and is consistent with the value of 55% reported by Yared et al. 13 We conservatively used the highest reported probability of obtaining a successful result upon redraw for samples below 3% fetal fraction: 74%. 14 As it is unlikely that "no-calls" lead to termination of pregnancy,
NIPS at low fetal fraction
we used the proportion of remaining patients receiving a positive NIPS call in Dar et al. 12 who elected invasive testing, 55%, to estimate the maximal rate at which patients receiving a "no-call" would seek invasive testing. This value agrees with the value of 57% reported for conventional first trimester screening. 15 The rate of procedure-related loss, 0.002, was obtained from Yaron.
23
To calculate the detection sensitivity for the WGS method for samples <2.8% fetal fraction, 14 we determined the frequency of observing samples in bins of 0.1% fetal fraction from 0 to 2.7% by fitting a beta distribution to the parameters reported in Nicolaides et al. 24 (median: 0.1; 25/75 percentiles: 0.078 and 0.13) using the 'optimize.brute' function in SciPy beginning with priors of zero and minimizing the sum of squares deviation from the 25th and 75th percentiles. 25 We then obtained the dot product of the sensitivity calculated at each fetal fraction bin multiplied by its relative prevalence among samples in the 0 to 2.7% range.
Statistics and Data
All statistics were calculated using SciPy in Python (version 0.17). 25 The output of all analyses as well as the Python code required to reproduce all results is available under the Creative Commons Attribution-NonCommercial 4.0 International Public License at https://github.com/counsylresearch/ artieri_et_al_nips_at_low_ff.
RESULTS
Comparing NIPS methods
To compare the WGS and SNP methods, we developed a computational framework with two steps: (1) simulation models that mimic the raw data generated by each method, and (2) aneuploidy-calling algorithms that process the simulated data and yield ploidy calls for trisomies in chromosomes 21, 18, and 13 (see Methods). The simulations allowed us to model an arbitrary number of pregnancies over a precise range of fetal fractions and calculate analytical performance in terms of both sensitivity and specificity. To ensure a fair comparison between methods, simulation parameters and calling algorithms were drawn directly from the most up-to-date published reports, such as peer-reviewed manuscripts and patents (see Methods). The WGS method partitions each chromosome into equal sized bins and tallies the number of reads per bin, normalized for GC content and repetitive regions (15) . Trisomies manifest as a higher number of reads per bin relative to the disomic background, with read excess proportional to the fetal fraction (e.g., 55 reads in trisomic chr21 bin vs 50 reads in disomic chr3, Figure 1 , top). In contrast, the SNP method measures relative counts among alleles at pre-selected, polymorphic sites on the chromosomes of interest. Trisomies manifest as a global shift in allelic counts relative to disomic chromosomes (Figure 1, bottom) .
Influence of parent-of-origin on SNP and WGS methods
The expected deviation in allele frequencies caused by aneuploidies in the SNP method differs based on the parentaland meiotic-stage of origin of the aneuploidy (Figure 2 ; Supplemental Figure S7 ), the rates of which vary substantially: 70% of nondisjunction events occur during maternal meiosis phase I (M1), leading to fetal inheritance of both maternal chromosomes, while 20% occur during meiosis phase II (M2), causing fetal inheritance of two copies of a single maternal chromosome. 27 The remaining nondisjunctions are paternal in origin, with 3% originating from M1, and 7% from M2 22 ( Figure 2a ). In the SNP method, paternally-derived trisomies produce a much stronger signal than do the more common maternal trisomies, illustrated by the shift in the red and blue distributions in Figure 2b . Because the majority of allelic counts in cfDNA are maternal in origin, paternally inherited trisomies nearly double the presence of paternal-specific alleles, whereas maternally-derived trisomies only slightly increase the signal of one of the two maternal alleles (~4%) ( Table 1) .
Conversely, in the WGS method, all four origins of trisomy produce the same signal: an elevated number of NGS reads mapping to the trisomic chromosome (Figure 2c) . Consequently, the sensitivity of the method is independent of the origin.
Specificity and sensitivity of both methods as a function of fetal fraction
We compared the performance of the two methods at low fetal fraction by simulating 10,000 samples of each possible origin of trisomy for chromosomes 21, 18 , and 13 at fetal fractions ranging from 0.1% to 4% (see Methods). Per-sample sequencing depths were obtained from published validation reports. 14, 17 We determined calling performance by generating receiveroperating characteristic (ROC) curves and calculating the area under the curve (AUC) for each method as a function of fetal fraction (Figure 3a, b) . 1 A test with high sensitivity and specificity will have AUC near 1. The SNP method calculates a likelihood that each chromosome is disomic or trisomic on a per-sample basis, returning a log-odds ratio (LOR) where disomic samples have positive LOR and trisomic samples have negative LOR. The SNP algorithm shows poor differentiation between disomic and trisomic LORs at low fetal fractions as an AUC of 0.99 is not achieved below fetal fractions of 3% (Figure 3a) . Setting a fetal fraction threshold below which all samples are "no-called" is thus appropriate to maintain SNPmethod performance.
14 In contrast, the WGS method processes~100 samples per batch and, for each sample and chromosome, assigns a z-score indicating the extent to which the counts in this sample deviate from the distribution of all other samples in the batch. 28 Because the expected distribution of disomic samples is independent of fetal fraction, its specificity is a function of the z-score threshold (z ≥ 3). 11 This is confirmed by the AUCs, which are greater than 0.99 at fetal fractions above 1.5% for all three common trisomies (Figure 3b ). To translate AUCs into sensitivities, we calculated the maximum attainable sensitivity of the SNP method at each fetal fraction while maintaining specificity ≥99.87% (corresponding to z ≥ 3 in the WGS method, see Methods). As expected, rare paternal trisomies could, in principle, be confidently detected at extremely low fetal fractions (Figure 3  c) . However, the most common fetal trisomies, maternal M1 nondisjunctions (70%), show the lowest sensitivity, with maternal M2 nondisjunctions (20%) falling in between the two extremes. We obtained the aggregate sensitivity of the SNP method at each fetal fraction by taking a prevalenceweighted sum of the sensitivities for each trisomic origin.
The sensitivity of the WGS method is dependent on the number of bins used to count reads and increases with chromosome size (Figure 1, top) . 19 Therefore, we calculated the sensitivity of the WGS method for each of the three common trisomies separately. In all cases, the SNP method shows lower aggregate sensitivity than the WGS method at low fetal fractions (Figure 3d ).
Clinical outcomes of low fetal fraction samples
Patients receiving a "no-call" have the option of sample redraw or invasive testing; however, not performing a follow-up test may lead to undiagnosed aneuploidies. Therefore, we assessed the T21 detection rate under two scenarios: 1) "no-calling" all samples below a fetal fraction of 2.8% (the most-recent no-call threshold reported by clinical laboratories using the SNP method 12 ), and 2) calling all such samples using the sensitivity parameters established from simulations of the WGS method. We first calculated the sensitivity of the WGS method for all samples below 2.8% fetal fraction by summing the prevalence-weighted sensitivity at each fetal fraction (Supplemental Figure S8) . 24 Applied to the simulated data, the WGS method shows a sensitivity of 86% for samples with fetal fraction <2.8%. Among patients initially receiving a "no-call" by the SNP method, approximately 42% will submit a redraw and receive a result (Figure 4a) . [12] [13] [14] Subsequently, the rate of invasive procedures among remaining patients will determine the proportion of aneuploidies that are detected (we assume that redraws and invasive testing are 100% sensitive to establish an upper limit on the detection rate). The invasive test rate among patients receiving a "no-call" would have to exceed 76% to equal the sensitivity of the WGS method, which is unlikely given the upper-limit estimate of 55% (Figure 4b ; see methods).
To illustrate the clinical consequences of systematically "nocalling" low fetal fraction samples, we assessed T21 screening outcomes for both methods on a simulated cohort of 10,000 Figure 1 Overview of the WGS and SNP methods. Both methods take advantage of NGS reads originating from the mixture of maternal and fetal cfDNA (in this example, fetal cfDNA constitutes 20% of the pool). The WGS method (top) divides the genome into equally-sized bins and counts the number of reads mapped to each bin. As illustrated, the presence of a fetus affected with trisomy 21 leads to an increase in the distribution of counts-per-bin originating from chromosome 21 (55 reads, red) relative to the euploid background (50 reads, gray). Detection of this increase forms the basis of the test. Alternatively, the SNP method (bottom) measures the relative abundance of alleles at polymorphic sites in the cfDNA. Fetal aneuploidies lead to predictable shifts in the frequency of allelic counts based on the possible combinations of maternal and fetal genotypes (see Figure 2) . By aggregating the signal across many SNPs on a given chromosome, the algorithm calculates a likelihood that the overall pattern of allele frequencies is more consistent with a normal versus an aneuploid fetus. The strength of the aneuploid signal in either method is proportional to the fetal fraction, and so too is the sensitivity of detection. Note that the number of reads illustrated in the figure are substantially lower than those published in validation reports (see Methods section).
initially low fetal fraction samples, assuming a trisomy 21 incidence of 3.3%, 10 and a rate of invasive testing of 55% after a "no-call" result ( Figure 4c ; see Methods). The WGS method would successfully detect 285 of the expected 330 cases (86%) but result in 45 false negatives. In comparison, the SNP method would detect 138 cases upon redraw, while 3,200 invasive procedures would be required to detect an additional 106 cases (74% detected), totaling 86 false negatives and six procedure-related pregnancy losses.
DISCUSSION
The vast majority of samples submitted for NIPS have sufficient fetal fraction to enable screening by both methods with excellent sensitivity, likely explaining why metaanalyses have noted comparable test performance. 4, 5, 9, 10 Nevertheless, we demonstrate that there are substantial performance differences between the two methodologies in low fetal fraction samples, leading to important clinical consequences. Figure 3 Comparison of performance characteristics of the two methods at low fetal fractions. Area-under the curve (AUC) values as a function of fetal fraction for the SNP (a) and WGS method (b) calling algorithms. The AUC captures the overall performance of disease classification and represents the probability that a random trisomic fetal sample would have a higher likelihood of aneuploidy in the SNP method (or a higher z-score than a random disomic sample in the WGS method).
1,2 The WGS method achieves AUC ≥ 95% for all three common trisomies at ≥1% fetal fraction. In contrast, the SNP method only achieves AUC ≥ 95% at fetal fractions ≥2.4%. The shaded areas above and below the curves represent the 95% confidence intervals on the estimates of AUC. C) Sensitivity of the SNP method at 99% specificity with respect to each of the trisomic origins (as both paternal non-disjunctions have identical sensitivity in this range, they are combined into a single category). The prevalence of each of the origins is shown as the white bar, while the colored bars indicate increasing fetal fraction in 1% intervals. Note that the sensitivity of the maternal M1 trisomy at 1% fetal fraction is zero, thus the leftmost bar is missing. Importantly, sensitivity is lowest for the most prevalent trisomies (maternal M1, 70%). D) Comparison of the sensitivities of the WGS method for each of the three common autosomal trisomies (gray bars) to the aggregate sensitivity of the SNP method (solid red bars). The aggregate sensitivity of the SNP method was obtained by summing the sensitivities scaled by prevalence across the three categories of trisomic origin. As illustrated by the simulations, the sensitivity of the WGS method improves with increasing chromosomal size. The aggregate sensitivity of the SNP method is shown as hollow bars at 1% and 2% fetal fraction as these are below the threshold at which all samples are "no-called". In panels C and D, groups of bars are separated by dotted lines as a visual aid Values are shown for a 10% fetal fraction, a maternal genotype, AA, and a fetal genotype, AB. Paternal trisomies will increase the frequency of the paternally inherited B allele almost two-fold over euploid expectations, while the increase of the frequency of the A allele only shifts the expected abundance of the B allele by 0.2% been well characterized, indicating that the results of our simulated model likely reflect biological reality for most patients. 19 A limitation of the SNP model is that two key parameters-the number of reads per SNP and the accuracy with which allele fractions are estimated-were inferred from published reports (see Supplemental Methods, Supplemental Figure S3 ). 12, 20, 29 Importantly, we show that even when these parameters are set to biologically unrealistic, theoretical ideals, the conclusions of the analysis remain unaltered (Supplemental Material, Supplemental Figures S4-6 ).
Performance of NIPS methods
By comparing each chromosome to a baseline disomic distribution, the WGS method maintains high specificity (≥ 99.87%), independent of fetal fraction (Figure 3b) . 11 In contrast, by evaluating the likelihood of aneuploidy on a sample-by-sample basis without a baseline expectation, the SNP method is unable to clearly distinguish disomic from trisomic samples at low fetal fractions. This justifies establishment of a threshold below which all samples are "no-called" (Figure 3a) . In fact, the threshold of 2.8% recently reported by Ryan et al. 14 agrees well with the value below which our simulations show a substantial drop in sensitivity (i.e., 3%, Figure 3c,d) .
A key determinant of the sensitivity of the SNP method in detecting trisomies is the origin of the nondisjunction event ( Figure 2) . The low sensitivity of detection of the most common type of nondisjunction (maternal M1, 70% of cases) overwhelms the improved sensitivity of the remaining types of nondisjunction, leading to overall poor test performance at low fetal fractions. Crucially, this performance deficit is not limited by the SNP method algorithm itself, but rather by the underlying biology of nondisjunction ( Figure 2b , Table 1 ). Indeed, any method measuring shifts in allele balances within the maternal-fetal mixture of cfDNA will have relatively reduced sensitivity in samples with the most common type of nondisjunction.
We also note that the results presented here model analytical sensitivities and specificities. Reported clinical sensitivities of NIPS have been higher for T21 when compared to T18 and T13. 9, 10 This is potentially due to T21 samples showing slightly elevated fetal fractions relative to disomic pregnancies, while Figure 4 Consequences of "no-calling" samples at low fetal fraction vs. reporting at reduced sensitivity. a) Clinical decision flowchart for samples receiving a "no-call" from the SNP method. Frequencies associated with each decision branch-point were obtained from published literature (see Methods). The outcomes of 10,000 samples that receive a "no-call" result are shown in the colored boxes. b) By summing the T21 sensitivity over the frequency of fetal fractions in the range of under which the SNP method reports a "no-call", the aggregate sensitivity of T21 detection of the WGS method is a constant 86% (black line). In contrast the SNP method (red line) is expected to detect 41% of aneuploid cases by re-draw (the intercept), while all further cases must be detected by invasive procedures. The gray line indicates a maximal estimate of the rate of patients consenting to invasive procedure given a "no-call" result (55%), which results in a total detection rate of 74%. FF, fetal fraction. c) Clinical consequences for 10,000 patients with fetal fraction below the 2.8% "no-call" threshold. 14 While the WGS method would detect 285 out of 330 expected cases of T21 (86%), the SNP method would detect 138 by NIPS (all due to redraw). In addition, 3,200 invasive procedures would be required to detect an additional 106 cases for a net sensitivity of 74%. This would also result in six procedure-related pregnancy loss (yellow line). The dotted line indicates the number of cases of T21 detected by the WGS method for comparison those of T18-and in some cases T13-have reportedly lower fetal fractions. 30, 31 In addition, fetal fraction is negatively correlated with maternal weight, further illustrating the importance of maximizing detection performance in low fetal fraction samples. 11, 13 Other factors that reduce clinical sensitivity, such as sample contamination and confined placental mosaicism, 32 should impact all NIPS methods as currently practiced. 9 Clinical consequences of no-calling low fetal fraction samples
Our model demonstrates that while setting a minimum fetal fraction threshold may help to maintain high per-patient analytical sensitivity, 3, 13, 33, 34 it may ultimately prove to be counter-productive. Based upon published clinical data, the probability of detecting a trisomy 21 case after an initial "no-call" using the SNP method is only~74% (Figure 4b ). This is almost certainly an overestimate as it is unlikely that patients who receive a "no-call" due to low fetal fraction will seek confirmatory invasive testing at the same rate as those who screen positive for T21. 12, 15 In contrast, the WGS model identifies a larger fraction of T21 fetuses, all noninvasively, obviating the need for invasive testing on failed samples (Figure 4c) . A major advantage of cfDNA-based NIPS over previous screening modalities is a tenfold reduction in the false-positive rate, which has vastly reduced the number of needless invasive procedures. 3, 23, 35 However, this benefit is undermined by tests with high failure rates, most commonly due to low fetal fraction. For example, nearly three-quarters of the projected overall test failure rate of the SNP method reported in Ryan et al. 14 was due to insufficient fetal fraction (3.8% low fetal fraction; 5.2% total failure rate). It is also notable that test failures are routinely excluded from claimed test sensitivity in published validation reports. 4, 23 This is especially important given that multiple studies have noted an increased rate of aneuploidies among patients who receive a "no-call". 3, 13, 36 For instance, the 100% sensitivity of T21 screening reported by Pergament et al. 36 drops to 86.5% if T21 positive fetuses among "no-calls" are counted among false negatives. 23 Barring an increase in the rate of invasive procedures-and the concomitant iatrogenic pregnancy loss that this entails-the findings of this study suggest that the most effective approach to improving fetal screening efforts is to implement methods that improve the performance of NIPS methods at low fetal fractions.
CONCLUSION
Via empirically informed simulation, we show that unlike the WGS approach, the SNP method cannot maintain high specificity and sensitivity at low fetal fractions, justifying its reliance on a minimal fetal fraction threshold for calling. 14 Finally, using published clinical data, we find that the WGS method detects a higher proportion of common aneuploidies in low fetal fraction samples than setting a "no-call" threshold, avoiding large numbers of invasive tests and associated complications.
WHAT'S ALREADY KNOWN ABOUT THIS TOPIC?
• The two most popular noninvasive prenatal screening (NIPS) methodologies, the single nucleotide polymorphism (SNP) and the whole-genome sequencing (WGS) methods, report comparable performance.
• However, failure rates vary by an order of magnitude between methodologies.
• A large component of failure is insufficient fetal fraction, creating "no-call" test results.
• The American Congress of Obstetricians and Gynecologists (ACOG) indicates that reported sensitivity is often inflated due to exclusion of failed samples from calculations.
WHAT DOES THIS STUDY ADD?
• The SNP method performs poorly at low fetal fraction on the most common fetal trisomy (maternal M1 nondisjunction).
• Offering invasive testing to all cases of "no-call" results will increase the rate of procedure-related loss.
• Compared to the SNP method, the WGS method maintains high specificity and can detect a higher proportion of aneuploidies in low fetal fraction samples without unnecessary invasive tests.
